Histone Methylation: Navigating the structure of COMPASS
Cryo-electron microscopy reveals how ubiquitination promotes the methylation of histone H3 by the histone-modifying complex COMPASS.
- Department of Biochemistry, University of Colorado, United States
Chromatin packages DNA by wrapping it around a core made of eight histone proteins to form individual units called nucleosomes which can be stored inside the nucleus (Luger et al., 1997). Each core contains four different types of histone, which each have flexible extensions called N-terminal tails. Certain modifications to these tails allow proteins to be recruited to the nucleosome, which can alter the structure of chromatin and make various regions of DNA more or less accessible. As a result, histone modifications regulate many genetic processes, including transcription, DNA repair and replication.
One modification that is particularly important for both transcription and repair is the addition of methyl groups to a lysine residue that sits within the N-terminal tail of histone H3 (Kouzarides, 2007). In yeast, methylation of this residue (also known as H3K4) relies on an enzyme called Set1 which forms part of the protein complex COMPASS (Figure 1A; Miller et al., 2001). Previous work has shown that for COMPASS to be recruited to the nucleosome, a ubiqutin group must be attached to a lysine residue in another histone called H2B (Kim et al., 2013). However, this lysine residue is far away from the N-terminal tail of H3: so why does COMPASS need H2B to be ubiquitinated in order to methylate this region?
Figure 1
How the COMPASS complex binds to the nucleosome.
(A) The COMPASS complex consists of six subunits including the enzyme Set1 (green) which methylates histone H3. When COMPASS binds to the nucleosome (not shown), three of its subunits (Swd3, Spp1 and Sd1) are slightly rotated towards the nucleosome (in the direction of the arrow; original positions shown in grey). (B) As well as rotating these three subunits, ubiquitination of the histone H2B (H2Bub; red) allows COMPASS to properly bind to the nucleosome and contact the DNA (black) at three distinct locations, including two which are at opposing ends of the nucleosome (indicated by *). Together these conformational changes help place the N-terminal tail of histone H3 (red dashed line) into the active site of Set1 so that H3 can be methylated. (C) Comparing COMPASS complexes which are bound to ubiquitinated (colored diagram) and non-ubiquitinated nucleosomes (light grey diagram) revealed that ubiquitin allows COMPASS to be in a better position for methylating the N-terminal tail of histone H3.
A common way to understand how histone modifying proteins interact with the nucleosome is to determine their structure using cryo-electron microscopy (Zhou et al., 2019; Worden et al., 2019). Now, in eLife, Evan Worden, Xiangbin Zhang and Cynthia Wolberger from Johns Hopkins University School of Medicine report how they used this technique to understand how COMPASS recognizes nucleosomes containing ubiquitinated H2B and uses this site to add a methyl group to histone H3 (Worden et al., 2020).
Worden et al. collaborated with another research group to develop a semi-synthetic H2B protein with a ubquitin chain attached to the correct lysine (Morgan et al., 2016). The team then used cryo-electron microscopy to produce a high-resolution structure of COMPASS from yeast that was bound to a nucleosome made with the semi-synthetic histone protein. This revealed that COMPASS spans the entire face of the nucleosome, making contacts with DNA at three distinct locations, two of which are at opposing edges of the nucleosome (Figure 1B).
The structure also showed that COMPASS makes extensive interactions with the histone core, molding itself over the surface of the nucleosome at the site where H2B binds together with another histone called H2A. Compared to structures of isolated COMPASS (Qu et al., 2018; Takahashi et al., 2011), three of the subunits in the bound complex were found to rotate towards the nucleosome and strengthen this interaction. This rotation also slightly shifts the position of the Set1 enzyme so that it can accept the H3 tail and allow methylation to occur (Figure 1A,B).
Worden et al. found that three of the COMPASS subunits cluster together to interact with the ubiquitin modification attached to the tip of H2B. This helps form a stronger attachment between COMPASS and H2B, and explains the preference for ubiquitinated nucleosomes. Additionally, this extensive interaction positions COMPASS so that the H3 tail can reach into the active site of the enzymatic subunit Set1. Although the tail of H3 is disordered as it emerges from the tightly-coiled DNA superhelix, it is still possible to see the tail tip sitting within the active site of COMPASS. This suggests that the N-terminal tail snakes around the outside of the nucleosome to reach the active site (Figure 1B,C). This could prohibit spontaneous conformational changes that expose regions of DNA (also known as DNA breathing) and affect the stability of the nucleosome.
Next, Worden et al. set out to find if the structural features predicted to be important for methylation had an effect in vivo. They found that introducing mutations which prevented COMPASS from interacting with the nucleosome, or which disrupted the interactions with the ubiquitin chains on H2B, led to reduced H3K4 methylation. These in vivo results represent a near-perfect match with the structural data and support this newly identified structure of COMPASS.
Other research groups have recently defined the structures of additional COMPASS complexes, including the human COMPASS complex MLL1 and a nucleosome-bound complex from a different strain of yeast (Park et al., 2019; Xue et al., 2019; Hsu et al., 2019). Out of the seven COMPASS structures determined, the three that were bound to ubiquitinated nucleosomes had nearly identical structures. The remaining four structures were bound to unmodified nucleosomes: whilst two of the structures had a similar conformation to COMPASS complexes bound to modified nucleosomes, in the other two structures COMPASS was rotated away from the histone core.
The structural differences between COMPASS proteins bound to modified and unmodified nucleosomes suggest that the ubiquitination of H2B (and the additional interactions with COMPASS) stabilizes the complex in a better position for promoting H3K4 methylation (Figure 1C). Taken together, these findings provide a new insight into how modifications across different histones can work together to regulate gene expression. Further work should focus on how the strength of the interaction between COMPASS and the ubiquitinated nucleosome influences the methylation of H3K4.
References
-
Cryo-EM structure of the human MLL1 core complex bound to the nucleosomeNature Communications 10:5540 .https://doi.org/10.1038/s41467-019-13550-2
-
Nucleosome structure and dynamics are coming of ageNature Structural & Molecular Biology 26:3–13.https://doi.org/10.1038/s41594-018-0166-x
Article and author information
Author details
Jonathan W Markert
Publication history
- Version of Record published: February 24, 2020 (version 1)
Copyright
© 2020, Luger and Markert
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,257
- Page views
-
- 135
- Downloads
-
- 0
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Histone Methylation: Navigating the structure of COMPASS
eLife 9:e54767.
https://doi.org/10.7554/eLife.54767
Further reading
-
- Chromosomes and Gene Expression
- Developmental Biology
Long noncoding RNAs (lncRNAs) are emerging as critical regulators of heart physiology and disease, although the studies unveiling their modes of action are still limited to few examples. We recently identified pCharme, a chromatin-associated lncRNA whose functional knockout in mice results in defective myogenesis and morphological remodeling of the cardiac muscle. Here, we combined Cap-Analysis of Gene Expression (CAGE), single-cell (sc)RNA sequencing, and whole-mount in situ hybridization analyses to study pCharme cardiac expression. Since the early steps of cardiomyogenesis, we found the lncRNA being specifically restricted to cardiomyocytes, where it assists the formation of specific nuclear condensates containing MATR3, as well as important RNAs for cardiac development. In line with the functional significance of these activities, pCharme ablation in mice results in a delayed maturation of cardiomyocytes, which ultimately leads to morphological alterations of the ventricular myocardium. Since congenital anomalies in myocardium are clinically relevant in humans and predispose patients to major complications, the identification of novel genes controlling cardiac morphology becomes crucial. Our study offers unique insights into a novel lncRNA-mediated regulatory mechanism promoting cardiomyocyte maturation and bears relevance to Charme locus for future theranostic applications.
-
- Cancer Biology
- Chromosomes and Gene Expression
Cancer is driven by both genetic and epigenetic changes that impact on gene expression profiles and the resulting tumourigenic phenotype. Enhancers are transcriptional regulatory elements that are key to our understanding of how this rewiring of gene expression is achieved in cancer cells. Here, we have harnessed the power of RNA-seq data from hundreds of patients with oesophageal adenocarcinoma (OAC) or its precursor state Barrett’s oesophagus coupled with open chromatin maps to identify potential enhancer RNAs and their associated enhancer regions in this cancer. We identify ~1000 OAC-specific enhancers and use these data to uncover new cellular pathways that are operational in OAC. Among these are enhancers for JUP, MYBL2, and CCNE1, and we show that their activity is required for cancer cell viability. We also demonstrate the clinical utility of our dataset for identifying disease stage and patient prognosis. Our data therefore identify an important set of regulatory elements that enhance our molecular understanding of OAC and point to potential new therapeutic directions.
